Are aromatase inhibiors and chemotheraphy associated with cognitive decline among breast cancer survivors? Findings from a large case/control study
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 52
(1)
◽
pp. 54-63
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 10
(1)
◽
pp. 21-30
◽
Keyword(s):
2019 ◽
Vol 28
(4)
◽
pp. 822-825
◽
Keyword(s):